Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker.
Parada CA, Osbun JW, Busald T, Karasozen Y, Kaur S, Shi M, Barber J, Adidharma W, Cimino PJ, Pan C, Gonzalez-Cuyar LF, Rostomily R, Born DE, Zhang J, Ferreira M Jr.
Parada CA, et al. Among authors: cimino pj.
Clin Cancer Res. 2020 Jan 1;26(1):193-205. doi: 10.1158/1078-0432.CCR-18-0641. Epub 2019 Oct 15.
Clin Cancer Res. 2020.
PMID: 31615938